Kalaris Therapeutics, Inc. KLRS
Set alert
2.09 USD +0.09 +4.50%
As of Nov 3, 2:05 PM ET
2.07 Day range 2.14
1.78 52-week range 11.88
- YTD
- -75.24%
- 1 year
- -58.12%
- Open
- 2.09
- Prev close
- 2.00
- Mkt cap
- 49.99M
- Vol
- 7.95K
- Avg vol
- 67.19K
- EPS
- -2.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.07
- High
- 2.14
Financials — quick view
KLRS Revenue — quarterly 0
KLRS Net income — quarterly -11.52M
KLRS EPS — quarterly -0.48
News
- Alpha Buying: 3 Beaten-Down Biotech Stocks Backed by a Specialist Investor
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Kalaris Therapeutics Inc. (NASDAQ:KLRS) Stock Has Average Price Target of $18.75
- Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference
- Kalaris Therapeutics Q2 EPS $(0.48) Beats $(0.49) Estimate
- Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Kalaris Therapeutics (NASDAQ:KLRS) Shares Up 15.4% – Here’s What Happened
- KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders
- Kalaris Therapeutics Appoints Liisa Bayko CFO
Your note
Sign in to keep a note on KLRS — it syncs with the Stock Master app.